A Systemically-Administered Small Molecule Antagonist of CCR9 Acts as a Tissue-Selective Inhibitor of Lymphocyte Trafficking

Por Tubo, Noah J., Wurbel, Marc A., Charvat, Trevor T., Schall, Thomas J., Walters, Matthew J., Campbell, James J.
Publicado em 2012